Medical Official: Iran-Made Cov-Pars Coronavirus Vaccine Unique in World
TEHRAN (FNA)- Chancellor of Iran University of Medical Sciences Jalil Kouhpayehzadeh said that the first injectable-inhaled coronavirus vaccine in the world, named Cov-Pars, is being produced and tested by the country’s Razi Vaccine and Serum Research Institute (RVSRI).
“The design and production of the vaccine started in a recombinant form by Razi Institute since the beginning of March last year and it is completely Iran-made and home-grown. The vaccine will be used in three doses. The initial dose is intramuscular, the second dose is injected intramuscularly after 21 days, and the third phase will be inhaled on the 51st day,” Kouhpayehzadeh, the executor of the plan to conduct the clinical trial of the Cov-Pars vaccine, told FNA on Saturday.
“Of course, there are recombinant vaccines in the world, but the feature making this vaccine unique is the last phase in which the vaccine should be inhaled” to prevent the person from being a carrier of the virus in addition to giving immunity to his/her body), he added.
Kouhpayehzadeh said that the vaccine is expected to create over 90% immunity in the body of recipients.
Iranian Health Minister Saeed Namaki said on Thursday that Iran will become an important hub for production and exports of coronavirus vaccine in two to three months.
"Iran will turn into one of the very important hubs for production of coronavirus vaccine in the region in the next two or three months and we will be one of the exporters of the vaccine in the world," Namaki said.
He added that after the coronavirus outbreak in Iran, the country has been able to add 2,500 new ICU beds to the hospitals.
Namaki had said last Sunday that his country will in the near future produce the best vaccines in the world, including the coronavirus vaccine.
“Iran will turn into an important vaccine production hub in the world in the next few months. We will produce the best vaccines in the world in the very near future,” Namaki said, addressing a ceremony to unveil the country’ first injectable-inhaled vaccine of Covid-19 recombinant protein produced at Razi institute.
He underlined Iran’s preparedness to produce new recombonent vaccines.
Namaki added that Iran will begin COVID-19 vaccination by using imported vaccines earlier this month.
The top priority groups of people for vaccination are doctors and nurses working at intensive care units of the hospitals, the minister said.
Namaki said that Iran has chosen and imported one of the least harmful and less dangerous vaccines after assessing the most credible vaccines available.
Iran insisted from the very beginning that it imports a vaccine only if it has already undertaken the third phase of its human trial, the minister said.
Iran has also provided some 16.8 million doses of COVID-19 vaccine from COVAX for vaccination of 8.4 million people, he said, noting that more vaccines are still needed to be imported.
Iran took delivery of the first batch of Sputnik-V vaccines from Russia on Thursday.
Iran in a parallel move to imports of vaccine is trying to produce home-made vaccine to fight against coronavirus.
Chairman of the Headquarters for Executing Imam Khomeini’s Order (HEIKO) Mohammad Mokhber underlined the capability of the Iran-made vaccine to deactivate the new British coronavirus, saying that the country hopes that the vaccine can also resist against other types of COVID-19 virus mutations.
“The Iranian vaccine has shown very excellent performance against the mutated coronavirus spreading in Britain and we hope that the Iran-made vaccine will succeed in confronting the future mutations of the coronavirus too,” Mokhber said earlier this month.
He added that infrastructures and facilities have been prepared to mass-produce the Iran-made coronavirus vaccine, adding that the country will be ready to produce 12mln to 14mln doses of the vaccine in mid spring.
Mokhber said that a number of world states have demanded to purchase the Iran-made vaccine, stressing that the Iranian citizens are a priority to receive the vaccine.